http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021322442-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7e6c02173d1fcbabd786fc286062d13
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
filingDate 2020-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7a24ef3c224c9722cb2aecf4cb62524
publicationDate 2021-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021322442-A1
titleOfInvention Long-term re-absorbable subcutaneous implant with controled pre-concentrated pharmacologically active polymer substance release for treating endometriosis
abstract The present invention is aimed at the medical sector and comprises a biodegradable implant of gestrinone in a polymeric matrix. The implant is inserted subdermally and has a continuous release of the asset for an extended period of time. This release aims to guarantee an efficient, constant and prolonged serum level of the drug for the treatment of endometriosis. The implant of the present invention may have only gestrinone in its constitution, but it is preferably formed by particles of gestrinone dispersed homogeneously in a bioerodible and bioabsorbable polymeric matrix. This polymeric matrix can be formed by a polymer or a mixture of polymers. The implants can have any size, shape or structure that facilitates their manufacture and insertion, however, to obtain a more constant and uniform release of the asset, it is necessary to use geometric shapes that maintain their surface area over time.
priorityDate 2020-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410455
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27812
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28417
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401586
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19917616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410920
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID108710621
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226571405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413271
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013

Total number of triples: 29.